Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
To print this article, all you need is to be registered or login on Mondaq.com.
EMA has launched a public consultation on revised guidance on the
development of new medicines to treat tuberculosis. The guidance is
an addendum to EMA's guideline on the evaluation of medicines
to treat bacterial infections. EMA will host a workshop in November
2016 to discuss stakeholders' comments on the revised guidance.
Stakeholders can send their comments to the Agency until January
31, 2017.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
EMA Consults On Development Of Medicines To Treat Tuberculosis
European UnionFood, Drugs, Healthcare, Life Sciences
Contributor
Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
